Matching articles for "July 16"
Issue 1265 · July 16, 2007
Thiazolidinediones and Cardiovascular Disease

The thiazolidinediones rosiglitazone (Avandia) and pioglitazone (Actos) are peripheral insulin sensitizing agents used to treat hyperglycemia in patients with type 2 diabetes; one or the other is often used as…

Med Lett Drugs Ther. 2007 Jul 16; 49(1265):57-8
The thiazolidinediones rosiglitazone (Avandia) and pioglitazone (Actos) are peripheral insulin sensitizing agents used to treat hyperglycemia in patients with type 2 diabetes; one or the other is often used as a second or third agent with metformin ( Glucophage , and others) and/or a sulfonylurea such as glimepiride ( Amaryl , and others). A recent report suggested that rosiglitazone may increase the incidence of myocardial infarction (MI) and cardiovascular mortality.
Issue 1265 · July 16, 2007
Lisdexamfetamine dimesylate (Vyvanse) for ADHD

Lisdexamfetamine dimesylate ( Vyvanse - Shire), a prodrug in which d-amphetamine is covalently bonded to L-lysine, has been approved by the FDA for treatment of attention-deficit/hyperactivity disorder (ADHD)…

Med Lett Drugs Ther. 2007 Jul 16; 49(1265):58-9
Lisdexamfetamine dimesylate ( Vyvanse - Shire), a prodrug in which d-amphetamine is covalently bonded to L-lysine, has been approved by the FDA for treatment of attention-deficit/hyperactivity disorder (ADHD) in children 6-12 years old. It was designed to have less potential than amphetamine itself for abuse, diversion or overdose toxicity. Like methylphenidate and amphetamines, lisdexamfetamine is a Schedule II controlled substance.
Issue 1265 · July 16, 2007 Free
Addendum: Dermal Fillers

Some Medical Letter consultants have suggested that our recent article on dermal fillers (Med Lett Drugs Ther 2007; 49:39) should have included stronger warnings about the risk of fillers that are not…

Med Lett Drugs Ther. 2007 Jul 16; 49(1265):59
Some Medical Letter consultants have suggested that our recent article on dermal fillers (Med Lett Drugs Ther 2007; 49:39) should have included stronger warnings about the risk of fillers that are not biodegradable, such as Artefill . The polymethylmethacrylate (PMMA, the same material that makes up Plexiglas ) beads in Artefill can over time, even with the best technique, cause foreignbody granulomas and hypertrophic scarring, which may require surgical removal. Granulomas and nodules have been especially frequent when Artefill was injected into the lips. Complications are less likely with hyaluronic acid products such as Hylaform , Juvéderm or Restylane . Download U.S. English .